Standout Papers
Immediate Impact
6 from Science/Nature 65 standout
Citing Papers
Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a randomised, open-label, phase 3b trial
2019 Standout
Antithrombotic Therapy for VTE Disease
2016 Standout
Works of John E. Markis being referenced
Hemorrhagic Events during Therapy with Recombinant Tissue-Type Plasminogen Activator, Heparin, and Aspirin for Acute Myocardial Infarction
1991
RANDOMISED CONTROLLED TRIAL OF RECOMBINANT TISSUE PLASMINOGEN ACTIVATOR VERSUS UROKINASE IN THE TREATMENT OF ACUTE PULMONARY EMBOLISM
1988
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| John E. Markis | 2376 | 858 | 1470 | 39 | 3.2k | |
| Alan J. Tiefenbrunn | 2619 | 966 | 1032 | 53 | 3.5k | |
| Kristina N. Sigmon | 2807 | 893 | 1794 | 53 | 3.5k | |
| Richard J. Candela | 2370 | 941 | 1413 | 30 | 2.8k | |
| Franz Hartmann | 3111 | 882 | 1556 | 91 | 4.0k | |
| Marco Tubaro | 2298 | 770 | 1033 | 85 | 3.3k | |
| Charles W. Abbottsmith | 2303 | 870 | 1405 | 34 | 2.7k | |
| Jean‐Marc Lablanche | 2970 | 1126 | 2053 | 66 | 3.9k | |
| John Ducas | 1752 | 638 | 1133 | 99 | 2.8k | |
| Marcus A. DeWood | 2579 | 1327 | 1470 | 35 | 3.3k | |
| Barry S. George | 3628 | 1581 | 2678 | 67 | 4.6k |
All Works
Loading papers...